Cell Therapy News Volume 25.02 | Jan 22 2024

    0
    38








    2024-01-22 | CTN 25.03


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.02 – 22 January, 2024
    TOP STORY

    Impact of Tumor Microenvironment on Efficacy of Anti-CD19 CAR T Cell Therapy or Chemotherapy and Transplant in Large B Cell Lymphoma

    The authors presented a prespecified exploratory analysis examining the association between pretreatment tumor characteristics and the efficacy of axi-cel versus standard of care.
    [Nature Medicine]

    Full Article
    Sign up to read articles, listen to our podcast, or download free toolkits to help you thrive as a scientist.
    PUBLICATIONSRanked by the impact factor of the journal

    Safety, Efficacy, and Determinants of Response of Allogeneic CD19-Specific CAR-NK Cells in CD19+ B Cell Tumors: A Phase I/II Trial

    Investigators conducted a Phase I/II trial of cord blood-derived natural killer cells expressing anti-CD19 chimeric antigen receptor and interleukin-15 in 37 patients with CD19+ B cell malignancies.
    [Nature Medicine]

    Full Article

    Allogeneic Stem Cell Therapy for Acute Ischemic Stroke

    Researchers assessed the efficacy and safety of MultiStem when administered within 18 to 36 hours of ischemic stroke onset via the Treatment Evaluation of Acute Stroke Using Regenerative Cells (TREASURE) multicenter, double-blind, parallel-group, placebo-controlled Phase II/III randomized clinical trial.
    [JAMA Neurology]

    Full Article

    Chronic Graft-versus-Host Disease Detected by Tissue-Specific Cell-Free DNA Methylation Biomarkers

    Investigators established a cocktail of tissue-specific DNA methylation markers and used it to determine the concentration of circulating cell-free DNA molecules derived from the liver, skin, lungs, colon, and specific immune cells in 101 patients undergoing hematopoietic stem cell transplantation.
    [Journal Of Clinical Investigation]

    Full ArticleGraphical Abstract

    Mesenchymal Stem Cells Overexpressing Xist Induce Macrophage M2 Polarization and Improve Neural Stem Cell Homeostatic Microenvironment, Alleviating Spinal Cord Injury

    Researchers investigated the potential of bone marrow-derived MSCs modified with X inactive specific transcript (XIST) lentiviral vector to modulate macrophage polarization and affect neural stem cell microenvironment reconstruction following spinal cord injury.
    [Journal Of Tissue Engineering]

    Full Article

    Long Term Stability of Clinical Grade Lentiviral Vectors for Cell Therapy

    Investigators conducted a thorough examination of essential stability attributes including vector titer, transduction efficiency, and potency for a series of clinical grade vector lots, each assessed at a minimum of 36 months following their date of manufacture.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull Article

    Neutrophil Extracellular Trap-Related Mechanisms in Acne Vulgaris Inspire a Novel Treatment Strategy with Adipose-Derived Stem Cells

    Scientists explored the potential role of adipose-derived stem cells and the potential mechanism associated with neutrophil extracellular traps in relieving acne vulgaris.
    [Scientific Reports]

    Full Article

    A Cell Therapy Approach Based on iPSC-Derived Midbrain Organoids for the Restoration of Motor Function in a Parkinson’s Disease Mouse Model

    By transplanting midbrain organoid cells into the striatum region of a 6-hydroxydopamine-lesioned Parkinson’s disease mouse model, researchers found that the transplanted cells survived and highly efficiently differentiated into dopaminergic neurons.
    [Heliyon]

    Full Article

    Immunomodulatory Performance of GMP-Compliant, Clinical-Grade Mesenchymal Stromal Cells from Four Different Sources

    Scientists evaluated the immunomodulatory effects of Good Manufacturing Practice (GMP)-compliant clinical grade MSCs obtained from four different sources on allogeneic peripheral blood mononuclear cells.
    [Heliyon]

    Full Article
    Meet the family of popular STEMCELL products. Click to explore.
    REVIEWS

    Clinical Applications of Stem Cell-Derived Exosomes

    Compared to stem cells, stem cell-derived exosomes possess numerous advantages, such as non-immunogenicity, non-infusion toxicity, easy access, effortless preservation, and freedom from tumorigenic potential and ethical issues.
    [Signal Transduction And Targeted Therapy]

    Full Article

    CAR-T Cell Manufacturing: Major Process Parameters and Next-Generation Strategies

    Investigators discuss the major process parameters of autologous CAR-T cell manufacturing, as well as regulatory considerations and ongoing developments that will enable the next generation of CAR-T cell therapies.
    [Journal Of Experimental Medicine]

    Full Article

    Chimeric Antigen Receptor-Based Natural Killer Cell Immunotherapy in Cancer: From Bench to Bedside

    The authors provide an updated understanding of NK cell development, functions, and their applications in disease therapy. They explored the rationale for utilizing engineered NK cell therapies, such as CAR-NK cells, and discuss the differences between CAR-T and CAR-NK cells.
    [Cell Death & Disease]

    Full Article

    INDUSTRY AND POLICY NEWS

    EPA Scraps Plan to End Mammal Testing by 2035

    The US Environmental Protection Agency (EPA) has abandoned a controversial plan to phase out all use of mammals to test the safety of chemicals by 2035.
    [Science Insider]

    Press Release

    Biomaterials Award Announcement 2024

    The Biomaterials Global Impact Award recognizes distinguished research and development accomplishments in the field of biomaterials. This year, the award will be shared by Professor Antonios Mikos of Rice University, and Dr. Ali Khademhosseini of Terasaki Institute for Biomedical Innovation.
    [Biomaterials]

    Press Release
    FEATURED EVENT

    2024 AAAAI Annual Meeting

    February 23 – 26, 2024
    Washington, DC, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientists – New Immune Checkpoints and Immunotherapies

    Albert Einstein College of Medicine – New York, New York, United States

    PhD Positions – Tissue Regeneration and Cancer Immunotherapy

    Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany

    Assistant Professor – Stem Cell Biology in Rare Diseases

    University of Alberta – Edmonton, Alberta, Canada

    Biotechnology Technician – Gene Therapy

    Roche – Penzberg, Germany

    Faculty Position – BioEngineering

    H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2